Drawing for RESEARCH EMPOWERED COMMUNITIES

USPTO serial 98111050

RESEARCH EMPOWERED COMMUNITIES

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
LOVELACE, JAMES B
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RESEARCH EMPOWERED COMMUNITIES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brian O'Donnell

Brian O'Donnell MORGAN, LEWIS & BOCKIUS LLP1111 PENNSYLVANIA AVENUE, NWWASHINGTON, DC 20004-2541United States

Goods and services

ClassDescriptionStatusFirst use
035Recruitment advertisement services, namely, contacting physicians for the purpose of recruiting patients for participation in clinical trials for the testing of drugs by means of direct methods of marketing, namely, e-mail marketing, SMS messaging, electronic medical record (EMR) messaging, in-clinic communications, in-clinic promotional material, and telephone calls, and indirect methods of marketing communications, namely, social media, search engine marketing, inquiry marketing, internet marketing, mobile marketing, blogging and other forms of passive, sharable or viral communications channels of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; promoting the interests of clinical research and clinical trials by means of facilitating community engagement; promoting awareness in the fields of clinical research and clinical trialsACTIVE—
042Medical and scientific research in the nature of conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials; Consulting services for others in the field of design, planning, and implementation project management of clinical trialsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 4, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 4, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 30, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 29, 2025EX2GSOU EXTENSION 2 GRANTED—
Sep 29, 2025EXT2SOU EXTENSION 2 FILED—
Sep 29, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 1, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 1, 2025EX1GSOU EXTENSION 1 GRANTED—
Apr 1, 2025EXT1SOU EXTENSION 1 FILED—
Mar 31, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 1, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 6, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 6, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 17, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 28, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 26, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 26, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 26, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 3, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 3, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 3, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 27, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 27, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 27, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 12, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 12, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 12, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 6, 2024DOCKASSIGNED TO EXAMINER—
Aug 30, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 4, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance